Dopaminergic synapse

Dopamine receptor agonists/antagonists

Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline

Reticuline biosynthesis, dopamine + 4HPAA => (S)-reticuline

DBH; dopamine beta-monooxygenase [EC:1.14.17.1]

DRD1; dopamine receptor D1

DRD2; dopamine receptor D2

DRD3; dopamine receptor D3

DRD4; dopamine receptor D4

K04147 dopamine receptor D4 | (RefSeq) DRD4, D4DR; dopamine receptor D4

K04144 dopamine receptor D1 | (RefSeq) DRD1, D1R, DADR, DRD1A; dopamine receptor D1

no KO assigned | (RefSeq) CDNF, ARMETL1; cerebral dopamine neurotrophic factor

K05840 dopamine receptor D5 | (RefSeq) DRD5, DBDR, DRD1B, DRD1L2; dopamine receptor D5

K05036 solute carrier family 6 (neurotransmitter transporter, dopamine) member 3 | (RefSeq) SLC6A3, DAT, DAT1, PKDYS, PKDYS1; solute carrier family 6 member 3

K04144 dopamine receptor D1 | F2-V_15549.1_B_pred_3_-_993_1072_2_P

K05840 dopamine receptor D5 | F2-W_100D24.y_B_pred_1_-_1_99_0_P

K05840 dopamine receptor D5 | [Complete]

K04145 dopamine receptor D2 | [Lack_5'-end]

K05036 solute carrier family 6 (neurotransmitter transporter, dopamine) member 3 | [Lack_5'-end]

Dopamine; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 3,4-Dihydroxyphenethylamine; 2-(3,4-Dihydroxyphenyl)ethylamine

N-Arachidonyldopamine; Arachidonoyl dopamine; NADA; N-(5Z,8Z,11Z,14Z-Eicosatetraenoyl)-dopamine

N-Oleoyldopamine

Dopamine 3-O-sulfate; Dopamine 3-sulfate

Dopamine 4-O-sulfate

3,4-dihydroxy-L-phenylalanine carboxy-lyase; 3,4-Dihydroxy-L-phenylalanine <=> Dopamine + CO2

monophenol,L-dopa:oxygen oxidoreductase; Tyramine + Oxygen + NADH + H+ <=> Dopamine + NAD+ + H2O

dopamine,ascorbate:oxygen oxidoreductase (beta-hydroxylating); Dopamine + 2 Ascorbate + Oxygen <=> L-Noradrenaline + 2 Monodehydroascorbate + H2O

3,4-dihydroxyphenylacetaldehyde hydro-lyase (adding dopamine); 3,4-Dihydroxyphenylacetaldehyde + Dopamine <=> (S)-Norlaudanosoline + H2O

4-(2-aminoethyl)-1,2-benzenediol:oxygen oxidoreductase(deaminating)(flavin-containing); Dopamine + H2O + Oxygen <=> 3,4-Dihydroxyphenylacetaldehyde + Ammonia + Hydrogen peroxide

dopamine beta-monooxygenase; dopamine beta-hydroxylase; MDBH (membrane-associated dopamine beta-monooxygenase); SDBH (soluble dopamine beta-monooxygenase); dopamine-B-hydroxylase; 3,4-dihydroxyphenethylamine beta-oxidase; 4-(2-aminoethyl)pyrocatecho • • •

aryl sulfotransferase; phenol sulfotransferase; sulfokinase; 1-naphthol phenol sulfotransferase; 2-naphtholsulfotransferase; 4-nitrocatechol sulfokinase; arylsulfotransferase; dopamine sulfotransferase; p-nitrophenol sulfotransferase; phenol sulfoki • • •

(S)-norcoclaurine synthase; (S)-norlaudanosoline synthase; 4-hydroxyphenylacetaldehyde hydro-lyase (adding dopamine); 4-hydroxyphenylacetaldehyde hydro-lyase [adding dopamine, (S)-norcoclaurine-forming]

deacetylisoipecoside synthase; deacetylisoipecoside dopamine-lyase; deacetylisoipecoside dopamine-lyase (secologanin-forming)

deacetylipecoside synthase; deacetylipecoside dopamine-lyase; deacetylipecoside dopamine-lyase (secologanin-forming)

Transport of dopamine to synaptic vesicle

Mutation-caused aberrant SNCA to transport of dopamine

Dopamine metabolism

Transport of dopamine into the neuron

Dopamine and serotonin metabolism

Dopamine beta-hydroxylase deficiency; Norepinephrine deficiency; Noradrenaline deficiency

Dopamine hydrochloride (JP18/USP); Actopamin (TN); Intropin (TN)

Oxidopamine (USAN/INN)

Dopamine (INN); Medopa (TN)

Dopamine

Dopamine D1-receptor agonist

Dopamine D2-receptor agonist

Dopamine agonist

Dopamine D2-receptor antagonist